Jianan Y. Huang
The First Affiliated Hospital Of Soochow University 188 Shizi Street
Suzhou, 215006, China
Suzhou, 215006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Expression levels of CSPG4 and SFRP1 in esophageal basaloid squamous cell carcinoma and their value in differential diagnosis
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: April 09, 2026
Autophagy-Related Molecular Signatures and Immune Profiles Distinguish Sepsis from Sepsis-Induced Acute Respiratory Distress Syndrome.
Journal: Combinatorial chemistry & high throughput screening
Published: November 27, 2025
Lipidomics reveals effect of EHHADH in lung squamous cell.
Journal: Cell biology and toxicology
Published: April 12, 2025
EBUS-guided Iodine-125 seed implantation in lymph node as a novel therapy for MCAO: A case report.
Journal: Medicine
Published: January 20, 2025
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer: The Phase 3 EXTENTORCH Randomized Clinical Trial.
Journal: JAMA oncology
Published: November 14, 2024
Camrelizumab plus carboplatin and pemetrexed as first-line therapy for advanced non-squamous non-small-cell lung cancer: 5-year outcomes of the CameL randomized phase 3 study.
Journal: Journal for immunotherapy of cancer
Published: October 10, 2024
Efficacy and Safety of KRASG12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 28, 2024
Prediction model and assessment of malnutrition in patients with stable chronic obstructive pulmonary disease.
Journal: Scientific reports
Published: November 27, 2023
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial.
Journal: The Lancet. Respiratory medicine
Published: July 06, 2023
Effects of concurrent TP53 mutations on the efficacy and prognosis of targeted therapy for advanced EGFR mutant lung adenocarcinoma.
Journal: Cancer genetics
Published: April 03, 2023
Demethylzeylasteral (T-96) Alleviates Allergic Asthma via Inhibiting MAPK/ERK and NF-κB Pathway.
Journal: International archives of allergy and immunology
Published: March 11, 2023
Last Updated: 09/26/2026